Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Sale of 14,051 DFTX shares, $513.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 14,051 | $513.8K |
| Sep 14, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 125,000 | n/a |
| Aug 12, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 62,500 | n/a |
| Jun 26, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 13,008 | $585.8K |
| Jun 22, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 62,500 | n/a |
| Mar 26, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 10,702 | $197.7K |
| Feb 5, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 125,000 | n/a |
| Dec 29, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Sale | 11,276 | $148.2K |
| Sep 26, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Sale | 11,278 | $110.2K |
| Jun 26, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Sale | 11,491 | $78.1K |